Metformin Use during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

被引:0
作者
Wink, Krista [1 ]
Belderbos, Jose [2 ]
Dieleman, Edith [3 ]
Rossi, Maddalena [2 ]
Rasch, Coen [3 ]
Damhuis, Ronald [4 ]
Houben, Ruud [1 ]
Troost, Esther [5 ,6 ]
机构
[1] Maastro Clin, Radiat Oncol, Maastricht, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[3] Amsterdam Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands
[4] Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands
[5] Med Fac, Dept Radiat Oncol, Dresden, Germany
[6] Univ Hosp Carl Gustav Carus, Dresden, Germany
关键词
NSCLC; metformin; Radiotherapy; Diabetes;
D O I
10.1016/j.jtho.2016.11.280
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OA09.06
引用
收藏
页码:S278 / S279
页数:2
相关论文
共 50 条
[21]   Are unsatisfactory outcomes after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer due to treatment-related immunosuppression? [J].
Thor, Maria ;
Montovano, Margaret ;
Hotca, Alexandra ;
Luo, Leo ;
Jackson, Andrew ;
Wu, Abraham J. ;
Deasy, Joseph O. ;
Rimner, Andreas .
RADIOTHERAPY AND ONCOLOGY, 2020, 143 :51-57
[22]   Chemoradiation for locally advanced non-small cell lung cancer [J].
Girard, N. ;
Mornex, F. .
CANCER RADIOTHERAPIE, 2007, 11 (1-2) :67-76
[23]   Locally Advanced, Unresectable Non-Small Cell Lung Cancer [J].
Puri, Sonam ;
Saltos, Andreas ;
Perez, Bradford ;
Le, Xiuning ;
Gray, Jhanelle E. .
CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
[24]   Comparison of the Efficacy and Toxicity of Concurrent Chemoradiotherapy and Durvalumab and Concurrent Chemoradiotherapy Alone for Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Metastasis [J].
Abe, Takanori ;
Iino, Misaki ;
Saito, Satoshi ;
Aoshika, Tomomi ;
Ryuno, Yasuhiro ;
Ohta, Tomohiro ;
Igari, Mitsunobu ;
Hirai, Ryuta ;
Kumazaki, Yu ;
Miura, Yu ;
Kaira, Kyoichi ;
Kagamu, Hiroshi ;
Noda, Shin-Ei ;
Kato, Shingo .
ANTICANCER RESEARCH, 2023, 43 (02) :675-682
[25]   Impact of antibiotic use before definitive concurrent chemoradiation in patients with locally advanced non-small cell lung cancer [J].
Mei, Ting ;
Yang, Xuexi ;
Yu, Min ;
Tian, Xiaoman ;
Deng, Qianyue ;
Chen, Xianyan ;
Gong, Youling .
STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (07) :645-657
[26]   Impact of antibiotic use before definitive concurrent chemoradiation in patients with locally advanced non-small cell lung cancer [J].
Ting Mei ;
Xuexi Yang ;
Min Yu ;
Xiaoman Tian ;
Qianyue Deng ;
Xianyan Chen ;
Youling Gong .
Strahlentherapie und Onkologie, 2023, 199 :645-657
[27]   Predictors of Post-chemoradiotherapy Pulmonary Complication in Locally Advanced Non-Small Cell Lung Cancer [J].
Lee, Tae Hoon ;
Kang, Byung-Hee ;
Kim, Hak Jae ;
Wu, Hong-Gyun ;
Lee, Joo Ho .
CANCER RESEARCH AND TREATMENT, 2023, 55 (03) :865-874
[28]   Evaluation of Chemoradiotherapy Toxicity in Geriatric Patients Diagnosed with Locally Advanced Non-Small Cell Lung Cancer [J].
Kizilgoz, Derya ;
Kabalak, Pinar Akin ;
Kavurgaci, Suna ;
Yilmaz, Ulku .
INTERNATIONAL JOURNAL OF GERONTOLOGY, 2023, 17 (04) :254-257
[29]   Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer [J].
Arrieta, Oscar ;
Varela-Santoyo, Edgar ;
Soto-Perez-de-Celis, Enrique ;
Sanchez-Reyes, Roberto ;
De la Torre-Vallejo, Martha ;
Muniz-Hernandez, Sae ;
Cardona, Andres F. .
BMC CANCER, 2016, 16
[30]   Oesophageal Toxicity and Hypofractionated Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer [J].
Tho, L. M. ;
Mahmood, R. ;
Leitch, M. ;
Brisbane, I. ;
Kakumanu, S. ;
Mohammed, N. .
CLINICAL ONCOLOGY, 2009, 21 (01) :74-74